Literature DB >> 25816778

Usefulness of N-terminal Pro-brain Natriuretic Peptide and Myocardial Perfusion in Asymptomatic Adults (from the Multi-Ethnic Study of Atherosclerosis).

Adam Mitchell1, Jeffrey R Misialek2, Aaron R Folsom2, Daniel Duprez1, Alvaro Alonso2, Michael Jerosch-Herold3, Otto A Sanchez2, Karol E Watson4, Tamer Sallam4, Suma H Konety5.   

Abstract

This study sought to investigate the relation between myocardial perfusion and N-terminal pro-brain natriuretic peptide (NT-proBNP) in asymptomatic adults without overt coronary artery disease. NT-proBNP is a cardiac neurohormone secreted from the ventricles in response to ventricular volume expansion and pressure overload and may also be elevated in the setting of reduced myocardial perfusion. We hypothesized that reduced myocardial perfusion reserve (MPR) would be associated with elevated NT-proBNP in participants free of overt cardiovascular disease. MPR was measured by cardiac magnetic resonance, before and after adenosine infusion, in 184 MESA participants (mean age 60 ± 10.4, 58% white, 42% Hispanic, 44% women) without overt cardiovascular disease. MPR was modeled as hyperemic myocardial blood flow (MBF) adjusted for MBF at rest. A linear regression analysis, adjusted for demographics, established cardiovascular risk factors, left ventricular mass, coronary calcium score, body mass index, and medications, was used to determine the association between MPR and NT-proBNP. Participants with low hyperemic MBF were more likely to be older, male, diabetic, and have higher blood pressure and higher coronary artery calcium score. Mean hyperemic MBF was 3.04 ± 0.829 ml/min/g. MPR was inversely associated with NT-proBNP levels. In a fully adjusted model, every 1-SD decrement in MPR was associated with a 21% increment in NT-proBNP (p = 0.04). In conclusion, MPR is inversely associated with NT-proBNP level in this cross-sectional study of asymptomatic adults free of overt coronary artery disease, suggesting that higher NT-proBNP levels may reflect subclinical myocardial microvascular dysfunction.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25816778      PMCID: PMC4414796          DOI: 10.1016/j.amjcard.2015.02.040

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

Review 1.  Understanding the coronary circulation through studies at the microvascular level.

Authors:  M L Marcus; W M Chilian; H Kanatsuka; K C Dellsperger; C L Eastham; K G Lamping
Journal:  Circulation       Date:  1990-07       Impact factor: 29.690

Review 2.  How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.

Authors:  Jenny A Doust; Eva Pietrzak; Annette Dobson; Paul Glasziou
Journal:  BMJ       Date:  2005-03-19

Review 3.  Maximal coronary flow and the concept of coronary vascular reserve.

Authors:  J I Hoffman
Journal:  Circulation       Date:  1984-08       Impact factor: 29.690

4.  Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study.

Authors:  S E Reis; R Holubkov; J S Lee; B Sharaf; N Reichek; W J Rogers; E G Walsh; A R Fuisz; R Kerensky; K M Detre; G Sopko; C J Pepine
Journal:  J Am Coll Cardiol       Date:  1999-05       Impact factor: 24.094

5.  Increased cardiac BNP expression associated with myocardial ischemia.

Authors:  J P Goetze; C Christoffersen; M Perko; H Arendrup; J F Rehfeld; J Kastrup; L B Nielsen
Journal:  FASEB J       Date:  2003-04-22       Impact factor: 5.191

6.  Coronary endothelial dysfunction in humans is associated with myocardial perfusion defects.

Authors:  D Hasdai; R J Gibbons; D R Holmes; S T Higano; A Lerman
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

7.  Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis.

Authors:  A M Zeiher; H Drexler; H Wollschläger; H Just
Journal:  Circulation       Date:  1991-11       Impact factor: 29.690

8.  Improving the primary prevention of cardiovascular events by using biomarkers to identify individuals with silent heart disease.

Authors:  M Adnan Nadir; Sushma Rekhraj; Li Wei; Tiong K Lim; John Davidson; Thomas M MacDonald; Chim C Lang; Ellie Dow; Allan D Struthers
Journal:  J Am Coll Cardiol       Date:  2012-08-22       Impact factor: 24.094

9.  Effects of brain (B-type) natriuretic peptide on coronary artery diameter and coronary hemodynamic variables in humans: comparison with effects on systemic hemodynamic variables.

Authors:  K Okumura; H Yasue; H Fujii; K Kugiyama; K Matsuyama; M Yoshimura; M Jougasaki; K Kikuta; H Kato; H Tanaka
Journal:  J Am Coll Cardiol       Date:  1995-02       Impact factor: 24.094

10.  Plasma natriuretic peptide levels and the risk of cardiovascular events and death.

Authors:  Thomas J Wang; Martin G Larson; Daniel Levy; Emelia J Benjamin; Eric P Leip; Torbjorn Omland; Philip A Wolf; Ramachandran S Vasan
Journal:  N Engl J Med       Date:  2004-02-12       Impact factor: 91.245

View more
  11 in total

1.  Association of Elevated NT-proBNP With Myocardial Fibrosis in the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Chia-Ying Liu; Susan R Heckbert; Shenghan Lai; Bharath Ambale-Venkatesh; Mohammad R Ostovaneh; Robyn L McClelland; João A C Lima; David A Bluemke
Journal:  J Am Coll Cardiol       Date:  2017-12-26       Impact factor: 24.094

2.  Novel biomarkers of coronary microvascular disease.

Authors:  Olivia Y Hung; Suegene K Lee; Parham Eshtehardi; Habib Samady
Journal:  Future Cardiol       Date:  2016-06-13

3.  Change in NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) Level and Risk of Dementia in Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Mohammad R Ostovaneh; Kasra Moazzami; Kihei Yoneyama; Bharath A Venkatesh; Susan R Heckbert; Colin O Wu; Steven Shea; Wendy S Post; Annette L Fitzpatrick; Gregory L Burke; Hossein Bahrami; Otto A Sanchez; Lori B Daniels; Erin D Michos; David A Bluemke; João A C Lima
Journal:  Hypertension       Date:  2019-12-23       Impact factor: 10.190

4.  Association of Longitudinal Changes in NT-proBNP With Changes in Left Atrial Volume and Function: MESA.

Authors:  Vinithra Varadarajan; Bharath Ambale-Venkatesh; Seo Young Hong; Mohammadali Habibi; Hiroshi Ashikaga; Colin O Wu; Lin Y Chen; Susan R Heckbert; David A Bluemke; Joao A C Lima
Journal:  Am J Hypertens       Date:  2021-06-22       Impact factor: 3.080

5.  Evaluation of Mineralocorticoid Receptor Antagonism on Changes in NT-proBNP Among Persons With HIV.

Authors:  Suman Srinivasa; Christopher deFilippi; Kathleen V Fitch; Sanjna Iyengar; Grace Shen; Tricia H Burdo; Allie R Walpert; Teressa S Thomas; Gail K Adler; Steven K Grinspoon
Journal:  J Endocr Soc       Date:  2021-11-19

6.  Pregnancy as a Window to Future Cardiovascular Health: Design and Implementation of the nuMoM2b Heart Health Study.

Authors:  David M Haas; Deborah B Ehrenthal; Matthew A Koch; Janet M Catov; Shannon E Barnes; Francesca Facco; Corette B Parker; Brian M Mercer; C Noel Bairey-Merz; Robert M Silver; Ronald J Wapner; Hyagriv N Simhan; Matthew K Hoffman; William A Grobman; Philip Greenland; Deborah A Wing; George R Saade; Samuel Parry; Phyllis C Zee; Uma M Reddy; Victoria L Pemberton; Dale R Burwen
Journal:  Am J Epidemiol       Date:  2016-01-28       Impact factor: 4.897

7.  N-Terminal pro-Brain Natriuretic Peptide and Associations With Brain Magnetic Resonance Imaging (MRI) Features in Middle Age: The CARDIA Brain MRI Study.

Authors:  Ian T Ferguson; Martine Elbejjani; Behnam Sabayan; David R Jacobs; Osorio Meirelles; Otto A Sanchez; Russell Tracy; Nick Bryan; Lenore J Launer
Journal:  Front Neurol       Date:  2018-05-07       Impact factor: 4.003

8.  Head-to-Head Comparison of the Incremental Predictive Value of The Three Established Risk Markers, Hs-troponin I, C-Reactive Protein, and NT-proBNP, in Coronary Artery Disease.

Authors:  Julius Nikorowitsch; Francisco Ojeda; Karl J Lackner; Renate B Schnabel; Stefan Blankenberg; Tanja Zeller; Mahir Karakas
Journal:  Biomolecules       Date:  2020-03-04

9.  N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.

Authors:  Erika Jones; Janet Wei; Michael D Nelson; May Bakir; Puja K Mehta; Chrisandra Shufelt; Margo Minissian; Behzad Sharif; Carl J Pepine; Eileen Handberg; Galen Cook-Wiens; George Sopko; C Noel Bairey Merz
Journal:  PLoS One       Date:  2020-12-03       Impact factor: 3.752

10.  Artificial Intelligence-Assisted Identification of Genetic Factors Predisposing High-Risk Individuals to Asymptomatic Heart Failure.

Authors:  Ning-I Yang; Chi-Hsiao Yeh; Tsung-Hsien Tsai; Yi-Ju Chou; Paul Wei-Che Hsu; Chun-Hsien Li; Yun-Hsuan Chan; Li-Tang Kuo; Chun-Tai Mao; Yu-Chiau Shyu; Ming-Jui Hung; Chi-Chun Lai; Huey-Kang Sytwu; Ting-Fen Tsai
Journal:  Cells       Date:  2021-09-15       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.